Explanation
BACKGROUND: Columbus Public Health has been awarded a grant from Gilead Sciences, Inc. This ordinance is needed to accept and appropriate a total of $310,750.00 in grant money to fund the FOCUS Hep C grant program, for the period of June 30, 2018 through June 30, 2019.
The FOCUS Hep C grant program will allow Columbus Public Health (CPH) to seek to reduce morbidity and mortality associated with Hepatitis C. Additional Hepatitis C screening will be made available through the Sexual Health and Alcohol and Other Drug programs. Persons who screen positive for Hepatitis C through these programs will be referred to a Linkage to Care Specialist. The client will be assessed for current health insurance status and enrolled in any available programs, including Medicare and Medicaid. The client will be assessed for readiness to be linked to care. Persons ready will be referred to available infectious disease specialists.
This ordinance is submitted as an emergency so as to allow the financial transaction to be posted in the city's accounting system as soon as possible. Up to date financial posting promotes accurate accounting and financial management.
FISCAL IMPACT: The FOCUS Hep C grant program is entirely funded by Gilead Sciences, Inc.
Title
To authorize and direct the Board of Health to accept a 2018-2019 Focus Hepatitis C grant from Gilead Sciences, Inc.; to authorize the appropriation of $310,750.00 from the unappropriated balance of the City Private Grants Fund; and to declare an emergency. ($310,750.00)
Body
WHEREAS, $310,750.00 in grant funds have been made available through Gilead Sciences, Inc. for the FOCUS Hep C Grant Program for the period of June 30, 2018 through June 30, 2019; and
WHEREAS, it is necessary to accept and appropriate these funds from Gilead Sciences, Inc. for the support of the FOCUS Hep C Grant Program; and
WHEREAS, this ordinance is submitted as an emergency so as to allow the financial transactio...
Click here for full text